DataLibraryResearch is tracking the market dynamics of the crisis in the Pharma & Healthcare industry amid lock-down changes in the supply chain.

Get detailed analysis of the COVID-19 impact on the Inhalable Drug Delivery Devices Market

Global Inhalable Drug Delivery Devices (IDDD) Market Opportunities and Forecast 2020-2027

  • DLR2642
  • 05 July, 2021
  • Pharma & Healthcare
  • Pages: 120
  • Global
Global Inhalable Drug Delivery Devices (IDDD) Market, By Product Type (pressurized metered-dose inhalers, nebulizers, dry powder inhalers, thermal vaporization aerosol devices, others.), By End-user (hospitals and clinics, ambulatory care center, home care, others), and opportunities and forecast 2020-2027

Inhalable Drug Delivery Devices (IDDD) Market Overview

The global Inhalable Drug Delivery Devices (IDDD) market is projected to expand at a moderate rate during the forecast period. Factors such as increasing prevalence and incidence of asthmatic cases, chronic and acute diseases are expected to drive the global Inhalable Drug Delivery Devices (IDDD) market during the forecast period. According to World Health Organization (WHO), around 300 million people globally are suffering from asthma.

Moreover, technological advancements in inhalable drugs delivery systems such as nebulizers, dry powder inhalers, pressurized metered-dose inhalers are expected to boost the market growth. Moreover, large-scale efforts of government and non-governmental organizations for spreading awareness about the disease along with rising R&D activities to find a cure for asthma, chronic and acute diseases are the other important factors expected to boost the growth of the Inhalable Drug Delivery Devices (IDDD) market in near future. In addition to this, growing health care expenditure and increasing demand for advanced drugs are further driving the expansion of this market globally.

On the downside, a lack of awareness among patients and health care providers about the disease in developing countries along with the high cost of devices is likely to hamper the global Inhalable Drug Delivery Devices (IDDD) market during the forecast period.

Covid-19 Impact on Healthcare Biometrics Market:

In addition, the current Healthcare Biometrics Market study offers a detailed analysis of the current COVID-19 pandemic impact on the market growth and its influence on the future growth of the Healthcare Biometrics Market. The recently published report demonstrates the elevation in the demand for the healthcare sector. The healthcare manufacturers have experienced long term as well as short term effect which includes supply shortages, panic buying and stocking, regulation changes as short-term whereas approval delays and possible trend variations in consumption could be perceived as long-term impacts of COVID-19 on the health and pharmaceutical market.

The increasing need for a cure has pushed vaccine research and manufacturers to the limit. In addition to this, panic conditions have already spurred the demand for many healthcare products and services which are discussed in detail in this report. Moreover, the impact of COVID-19 on overall market revenue for the base year 2020 and its projection up to 2027 is provided in detail in this report.

Inhalable Drug Delivery Devices (IDDD) Market Segment Overview

Based on product type the market is segmented into pressurized metered-dose inhalers, nebulizers, dry powder inhalers, thermal vaporization aerosol devices, and others of which the dry powder inhalers segment holds the largest share of the market. This is because these products are highly effective to treat and show better results in comparison with other forms.

Based on End-user, the market is segmented into hospitals and clinics, ambulatory care centers, home care, and others, of which the hospitals and clinics segment is expected to grow at the highest rate in the coming years. The rising number of hospital admissions due to Chronic Obstructive Pulmonary Diseases (COPD) and asthma is also a major factor that’s driving the demand for Inhalable Drug Delivery Devices (IDDD)s.

Inhalable Drug Delivery Devices (IDDD) Market, By Product Type

·       Pressurized metered-dose inhalers
·       Nebulizers
·       Dry powder inhalers
·       Thermal vaporization aerosol devices
·       Others.

Inhalable Drug Delivery Devices (IDDD) Market, By End-user

·       Hospitals and clinics
·       Ambulatory care center
·       Homecare
·       Others

Inhalable Drug Delivery Devices (IDDD) Market Regional Overview

Region-wise, North America dominated the global Inhalable Drug Delivery Devices (IDDD) market and is expected to continue its dominance during the forecast period. Factors such as advanced technology, rising awareness among people about the diagnosis of the disease, and high health care expenditure propel the growth of the market in North America. similarly, Europe is also expected to account for a significant share of the global market owing to well-established health care infrastructure. Additionally, both regions show a high market share for Inhalable Drug Delivery Devices (IDDD) owning to the various awareness programs conducted by governments, organizations, and companies to improve treatment options for COPD.

Inhalable Drug Delivery Devices (IDDD) Market, By Geography

·       North America (US & Canada)
·       Europe (UK, Germany, France, Italy, Spain, & Rest of Europe)
·       Asia-Pacific (Japan, China, India, Australia, & South Korea, & Rest of Asia-Pacific)
·       LAMEA (Brazil, Saudi Arabia, UAE & Rest of LAMEA)

Inhalable Drug Delivery Devices (IDDD) Market Competitor overview

Some key developments and strategies adopted by manufacturers in the Inhalable Drug Delivery Devices (IDDD) are highlighted below.

·       In April 2021, Cipla launched Niveoli-the first extra-fine particle inhaler developed in India. The inhaler comprises beclomethasone-formoterol and hydrofluoroalkane (HFA), which ensures targeted delivery to small airways in asthma and COPD patients. 

Inhalable Drug Delivery Devices (IDDD) Market, Key Players

·       Bespak
·       Propeller Health
·       Boehringer Ingelheim International GmbH
·       OMRON Corporation
·       GlaxoSmithKline plc
·       AstraZeneca
·       Sunovion Pharmaceuticals Inc.
·       Pfizer Inc.
·       F. Hoffmann-La Roche Ltd
·       Monaghan Medical Corporation.

Inhalable Drug Delivery Devices (IDDD) Market Study Global Market Analysis, Insights and Forecast, 2020-2027

    1. Introduction

    • 1.1. Research Scope
    • 1.2. Market Segmentation
    • 1.3. Research Methodology
    • 1.4. Definitions and Assumptions

    2. Executive Summary

      3. Market Dynamics

      • 3.1. Market Drivers
      • 3.2. Market Restraints
      • 3.3. Market Opportunities

      4. Key Insights

      • 4.1. Key Emerging Trends – For Major Countries
      • 4.2. Latest Technological Advancement
      • 4.3. Regulatory Landscape
      • 4.4. Industry SWOT Analysis
      • 4.5. Porters Five Forces Analysis

      5. Global Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 5.1. Key Findings / Summary
      • 5.2. Market Analysis, Insights and Forecast – By Product Type
        • 5.2.1. Pressurized metered-dose inhalers
        • 5.2.2. Nebulizers
        • 5.2.3. Dry powder inhalers
        • 5.2.4. Thermal vaporization aerosol devices
        • 5.2.5. Others.
      • 5.3. Market Analysis, Insights and Forecast – By End-user
        • 5.3.1. Hospitals and clinics
        • 5.3.2. Ambulatory care center
        • 5.3.3. Home care
        • 5.3.4. Others
      • 5.4. Market Analysis, Insights and Forecast – By Region
        • 5.4.1. North America
        • 5.4.2. Europe
        • 5.4.3. Asia Pacific
        • 5.4.4. Latin America, Middle East, and Africa

      6. North America Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 6.1. Key Findings / Summary
      • 6.2. Market Analysis, Insights and Forecast – By Product Type
        • 6.2.1. Pressurized metered-dose inhalers
        • 6.2.2. Nebulizers
        • 6.2.3. Dry powder inhalers
        • 6.2.4. Thermal vaporization aerosol devices
        • 6.2.5. Others.
      • 6.3. Market Analysis, Insights and Forecast – By End-user
        • 6.3.1. Hospitals and clinics
        • 6.3.2. Ambulatory care center
        • 6.3.3. Home care
        • 6.3.4. Others
      • 6.4. Market Analysis, Insights and Forecast – By Country
        • 6.4.1. U.S.
        • 6.4.2. Canada

      7. Europe Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 7.1. Key Findings / Summary
      • 7.2. Market Analysis, Insights and Forecast – By Product Type
        • 7.2.1. Pressurized metered-dose inhalers
        • 7.2.2. Nebulizers
        • 7.2.3. Dry powder inhalers
        • 7.2.4. Thermal vaporization aerosol devices
        • 7.2.5. Others.
      • 7.3. Market Analysis, Insights and Forecast – By End-user
        • 7.3.1. Hospitals and clinics
        • 7.3.2. Ambulatory care center
        • 7.3.3. Home care
        • 7.3.4. Others
      • 7.4. Market Analysis, Insights and Forecast – By Country
        • 7.4.1. UK
        • 7.4.2. Germany
        • 7.4.3. France
        • 7.4.4. Italy
        • 7.4.5. Spain
        • 7.4.6. Russia
        • 7.4.7. Rest of Europe

      8. Asia Pacific Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 8.1. Key Findings / Summary
      • 8.2. Market Analysis, Insights and Forecast – By Product Type
        • 8.2.1. Pressurized metered-dose inhalers
        • 8.2.2. Nebulizers
        • 8.2.3. Dry powder inhalers
        • 8.2.4. Thermal vaporization aerosol devices
        • 8.2.5. Others.
      • 8.3. Market Analysis, Insights and Forecast – By End-user
        • 8.3.1. Hospitals and clinics
        • 8.3.2. Ambulatory care center
        • 8.3.3. Home care
        • 8.3.4. Others
      • 8.4. Market Analysis, Insights and Forecast – By Country
        • 8.4.1. China
        • 8.4.2. India
        • 8.4.3. Japan
        • 8.4.4. Australia
        • 8.4.5. South East Asia
        • 8.4.6. Rest of Asia Pacific

      9. Latin America, Middle East, and Africa Inhalable Drug Delivery Devices (IDDD) Market Analysis (USD Billion), Insights and Forecast, 2020-2027

      • 9.1. Key Findings / Summary
      • 9.2. Market Analysis, Insights and Forecast – By Product Type
        • 9.2.1. Pressurized metered-dose inhalers
        • 9.2.2. Nebulizers
        • 9.2.3. Dry powder inhalers
        • 9.2.4. Thermal vaporization aerosol devices
        • 9.2.5. Others.
      • 9.3. Market Analysis, Insights and Forecast – By End-user
        • 9.3.1. Hospitals and clinics
        • 9.3.2. Ambulatory care center
        • 9.3.3. Home care
        • 9.3.4. Others
      • 9.4. Market Analysis, Insights and Forecast – By Country
        • 9.4.1. Brazil
        • 9.4.2. Saudi Arabia
        • 9.4.3. UAE
        • 9.4.4. Rest of LAMEA

      10. Competitive Analysis

      • 10.1. Company Market Share Analysis, 2018
      • 10.2. Key Industry Developments
      • 10.3. Company Profile
      • 10.4. Bespak
        • 10.4.1. Business Overview
        • 10.4.2. Segment 1 & Service Offering
        • 10.4.3. Overall Revenue
        • 10.4.4. Geographic Presence
        • 10.4.5. Recent Development
      *Similar details will be provided for the following companies
      • 10.5. Propeller Health
      • 10.6. Boehringer Ingelheim International GmbH
      • 10.7. OMRON Corporation
      • 10.8. GlaxoSmithKline plc
      • 10.9. AstraZeneca
      • 10.10. Sunovion Pharmaceuticals Inc.
      • 10.11. Pfizer Inc.
      • 10.12. F. Hoffmann-La Roche Ltd

      Report You Might be Interested

      Choose License Type

      • USD
      • GBP
      • EURO
      • INR
      Credit card Logo

      Happy To Assist You

      Have a Question? email us at

      info@datalibraryresearch.com

      Or Call Us On

      US +1 360 851 1343

      IND +91 880 579 4934